ClinicalTrials.gov

Key Record Dates

ClinicalTrials.gov Identifier: NCT01116232
Brief Title: Sirolimus, Tacrolimus, Thymoglobulin and Rituximab as Graft-versus-Host-Disease Prophylaxis in Patients Undergoing Haploidentical and HLA Partially Matched Donor Hematopoietic Cell Transplantation

First Submitted : May 3, 2010
First Submitted that Met QC Criteria : May 3, 2010
First Posted : May 4, 2010 (Estimate)

Results First Submitted : October 22, 2013
Results First Submitted that Met QC Criteria : October 22, 2013
Results First Posted : December 13, 2013 (Estimate)

Last Update Submitted that Met QC Criteria : May 16, 2018
Last Update Posted : June 18, 2018